Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07480811
What this trial is testing

The Effect of the DASH Diet on Clinical and Metabolic Parameters in Children With MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Antalya Training and Research Hospital 88
Testing effectiveness (Phase 2)Looking for participantsNCT05648214
What this trial is testing

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Healthy VolunteersMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Regeneron Pharmaceuticals 172
Testing effectiveness (Phase 2)Study completedNCT06482112
What this trial is testing

Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNon-alcoholic Fatty Liver DiseaseNonalcoholic Fatty Liver Disease+1 more
Merck Sharp & Dohme LLC 124
Not applicableLooking for participantsNCT07083336
What this trial is testing

Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0)

Who this might be right for
Type 2 Diabetes MellitusMetabolic Dysfunction-associated Steatotic Liver Disease
State Key Laboratory of Subhealth Intervention Technology 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07517276
What this trial is testing

TUDCA in High-Risk Lactating Mothers Identified by Early Postpartum Milk Hydrophobicity Index

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease Infant Development
Peking University First Hospital 80
Not applicableNot Yet RecruitingNCT06797596
What this trial is testing

Clinical Correlation Evaluation of the LIVERFASt Test for Diagnosing Important Liver Lesions of Fibrosis and Steatosis Against Magnetic Resonance Elastography (MRE) for Liver Fibrosis and MR-based Assessment of Steatosis, in Adult US Population.

Who this might be right for
Liver Fibrosis Due to NASHMASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseAlcohol Liver Disease
Fibronostics USA, Inc 100
Not applicableLooking for participantsNCT07552727
What this trial is testing

Rehabilitation With Exercise-Based Intervention for Nonalcoholic Chronic Hepatic Esteatosis

Who this might be right for
Metabolic Adaptation to High-Intensity Interval TrainingMetabolic Associated-dysfunction Steatotic Liver Disease (MASLD)
Universidad San Sebastián 30
Not applicableStudy completedNCT07304336
What this trial is testing

Dietary Strategies for MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)

Who this might be right for
MASLD
University of Turin, Italy 173
Not applicableLooking for participantsNCT07330830
What this trial is testing

Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Population (AdipoDROMExpo)

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
Centre Hospitalier Universitaire de la Guadeloupe 600
Post-approval studies (Phase 4)Looking for participantsNCT06374875
What this trial is testing

Fibrosis Lessens After Metabolic Surgery

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)Non-Alcoholic Fatty Liver DiseaseMetabolic Dysfunction-Associated Steatohepatitis (MASH)+2 more
The Cleveland Clinic 120
Not applicableStudy completedNCT06352697
What this trial is testing

Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults MASLD Patients (DELI_MASLD Study)

Who this might be right for
Metabolic Dysfunction Associated Steatotic Liver DiseaseSteatotic Liver DiseaseHepatic Steatosis
Bogomolets National Medical University 52
Not applicableStudy completedNCT06741111
What this trial is testing

A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up Database

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) & Steatohepatitis (MASH)
Novo Nordisk A/S 1,233,970
Not applicableLooking for participantsNCT06619808
What this trial is testing

Hyperbaric Oxygen Therapy for Metabolic Dysfunction-associated Steatotic Liver Diseases

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver DiseaseHepatic SteatosisNon-alcoholic Fatty Liver Diseases
Jinling Hospital, China 150
Testing effectiveness (Phase 2)Study completedNCT04555434
What this trial is testing

Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
Chuncheon Sacred Heart Hospital 89
Not applicableStudy completedNCT07366463
What this trial is testing

Integrating Hepatological, Nutritional, and Psychological Support as a Multidisciplinary Management to Improve Long-term Clinical Outcomes in MASLD

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseMASLDCardiovascular Events
University of Campania Luigi Vanvitelli 286
Not applicableLooking for participantsNCT07068191
What this trial is testing

Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)HepatomegalyNonalcoholic Fatty Liver (NAFL)+5 more
Phenomen Pharma 90
Not applicableActive Not RecruitingNCT06662851
What this trial is testing

Usefulness of Ultrasound-derived Fat Fraction for Quantification of Hepatic Steatosis in Patients Suspected of MASLD

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
So Yeon Kim 150
Not applicableNot Yet RecruitingNCT07730853
What this trial is testing

Isocaloric Navy-Bean Substitution in Adults With MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Liver FibrosisMetabolic Dysfunction-Associated Steatohepatitis (MASH)
Icahn School of Medicine at Mount Sinai 40
Post-approval studies (Phase 4)Not Yet RecruitingNCT06762223
What this trial is testing

Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver DiseaseType 2 Diabetes Mellitus
Xiqiao Zhou 190
Not applicableNot Yet RecruitingNCT07731360
What this trial is testing

Non-Invasive Diagnostic Panel for MASLD in Children With Obesity

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseasePediatric ObesityInsulin Resistance Syndrome
Kayseri City Hospital 180
Next Page